Urological Complications and Management After Gynecological Operations

July 31, 2019 updated by: Acibadem University

OBJECTIVE: In the study, investigators aimed to evaluate the urological complications of gynecologic operations in a tertiary academic center and to evaluate the treatment methods of these complications.

METHODS: The files of all patients who underwent gynecological surgery between January 2016 and January 2019 were retrospectively reviewed. The age of patients with urological complications, American Anesthesia Society score, menopausal status, body mass index (BMI), preoperative hemoglobin level, postoperative hemoglobin level and hospitalization duration and number of previous surgeries were recorded. In addition, the patients with urological complications were evaluated in terms of the indications for surgery, type of surgery, type of urological complication and the way of treatment of the complication.

Study Overview

Detailed Description

In women, the anatomical localization of urinary and genital tracts is very close to each other. This proximity can lead to injuries during pelvic operations. Advances in gynecologic operation techniques and the growing experience of gynecologists may suggest a decrease in urological injuries. However, according to the literature, gynecologists face approximately 0.2% to 1% urinary tract injuries during pelvic surgeries. The increase in the number of recurrent surgeries and adverse situations encountered during the operations such as adhesions and anatomical variations factor into the persistence of urologic complications. Investigators aimed to evaluate the urological complications of gynecologic operations in a tertiary academic center and to evaluate the treatment methods of these complications.

The files of all patients who underwent gynecological surgery between January 2016 and January 2019 were retrospectively reviewed. The age of patients with urological complications, American Anesthesia Society score, menopausal status, body mass index (BMI), preoperative hemoglobin level, postoperative hemoglobin level and hospitalization duration and number of previous surgeries were recorded. In addition, the patients with urological complications were evaluated in terms of the indications for surgery, type of surgery, type of urological complication and the way of treatment of the complication.

Study Type

Observational

Enrollment (Actual)

1754

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

gynecologic operations with urologic complications Patients' previous medical records, detailed physical examination findings, age, menopausal status, American Society of Anesthesiologists Classification (ASA) scores, and body mass indexes (BMI) were noted. Also, preoperative hemoglobin levels, postoperative hemoglobin levels, and hospitalization durations were recorded. In addition, indications for gynecologic surgery, sites of injury and management modalities of injury were recorded

Description

Inclusion Criteria:

-Gynecologic operations with urologic complications

Exclusion Criteria:

  • Patients with incomplete data and patients who underwent obstetric operations
  • patients aged under 18
  • patients who were operated under emergency conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
gynecologic operations with urologic complications

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number and type of Urological Complications and Management After Gynecological Operations
Time Frame: retrospective 3 years period
retrospective 3 years period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2016

Primary Completion (ACTUAL)

January 1, 2019

Study Completion (ACTUAL)

January 1, 2019

Study Registration Dates

First Submitted

July 6, 2019

First Submitted That Met QC Criteria

July 31, 2019

First Posted (ACTUAL)

August 1, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 1, 2019

Last Update Submitted That Met QC Criteria

July 31, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • AcibademUr

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecologic Disease

Clinical Trials on gynecologic operations with urological complications

Subscribe